To mimic the BM microenvironment we co-cultured CP-CML CD34+ cells with the stroma cell line HS-5 to investigate the stroma-leukaemia cell interaction and measure the effectiveness of our inhibitors. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.